Disclosure Of Entity's Operating Segments [Text Block]

Mithra Pharmaceuticals S.A. - Filing #3183195

Concept As at
2021-12-31
2021-01-01 to
2021-12-31
2021-01-01 to
2021-12-31
2020-01-01 to
2020-12-31
As at
2020-12-31
2020-01-01 to
2020-12-31
Disclosure of entity's operating segments [text block]
Disclosure of operating segments [text block]
Disclosure of operating segments [abstract]
Disclosure of operating segments [line items]
Revenue
22,668,000 EUR
9 030 EUR
Tax expense (income)
6 895 EUR
18,835,000 EUR
Profit (loss) before tax
123 769 EUR
110 922 EUR
Profit (loss)
116 875 EUR
116 875 EUR
92 086 EUR
92 086 EUR
Assets
421 918 EUR
521 985 EUR
Cash flows from (used in) operating activities
74 387 EUR
80 025 EUR
Cash flows from (used in) investing activities
54 682 EUR
16 207 EUR
Cash flows from (used in) financing activities
23 245 EUR
185 187 EUR
Disclosure of products and services [text block]
Disclosure of products and services [abstract]
Disclosure of products and services [line items]
Disclosure of geographical areas [text block]
Disclosure of geographical areas [abstract]
Disclosure of geographical areas [line items]
Disclosure of major customers [text block]
Disclosure of major customers [abstract]
Disclosure of major customers [line items]

Talk to a Data Expert

Have a question? We'll get back to you promptly.